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qualitative study of cancer patients’
experiences
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Abstract
Background: Despite smoking and risky alcohol drinking being modifiable risk factors for cancer as well as postoperative
complications, perioperative cessation counselling is often ignored. Little is known about how cancer patients experience
smoking and alcohol interventions in relation to surgery. Therefore the aim of this study was to explore how bladder
cancer patients experience a perioperative smoking and alcohol cessation intervention in relation to radical cystectomy.
Methods: A qualitative study was conducted in two urology out-patient clinics. We conducted semi-structured in-depth
interviews with 11 purposively sampled persons who had received the smoking and alcohol cessation intervention. The
analysis followed the steps contained in the thematic network analysis.
Results: Two global themes emerged: “smoking and alcohol cessation was experienced as an integral part of bladder
cancer surgery” and “returning to everyday life was a barrier for continued smoking cessation/alcohol reduction”.
Participants described that during hospitalization their focus shifted to the operation and they did not experience craving
to smoke or drink alcohol. Concurrent with improved well-being or experiencing stressful situations, the risk of relapse
increased when returning to everyday life.
Conclusions: The smoking and alcohol cessation intervention was well received by the participants. Cancer surgery
served as a kind of refuge and was a useful cue for motivating patients to quit smoking and to reconsider the
consequences of risky drinking. These results adds to the sparse evidence of what supports smoking and alcohol
cessation in relation to bladder cancer patients undergoing major surgery and point to the need to educate healthcare
professionals in offering smoking and alcohol cessation interventions in hospitals. The study also provides knowledge
about the intervention in the STOP-OP study and will help guide the design of future smoking and alcohol cessation
studies aimed at cancer patients undergoing surgery.
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Background
Radical cystectomy is a highly morbid procedure and
complication rates vary from 30 to 64% [1, 2] regardless
of operative technique [3]. Both smoking and risky
alcohol drinking are modifiable risk factors for cancer as
well as postoperative complications [4–6]. In addition,
smoking is the major and most modifiable risk factor for
development of bladder cancer [7]. Continued smoking
and risky alcohol drinking affect pathophysiological
mechanisms, such as tissue perfusion and oxygen
delivery, ciliary and immune function, surgical stress re-
sponse, arrhythmias, and bleeding time [8–10], all of
which are beneficial for postoperative recovery. Observa-
tional studies show that smoking cessation reduces the
risk of recurrence and cancer related death [11] while
continued smoking leads to decreased survival, de-
creased quality of life and increased risk of readmission
within 30 days in bladder cancer patients [12–14].
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Interventional studies show that intensive smoking and
alcohol cessation intervention 6–8 weeks before elective
surgery reduces the incidence of postoperative morbidity
to about half [5, 6, 15] while a programme with one pre-
operative meeting showed no effect on surgical risk
reduction for other groups of cancer patients undergoing
surgery [5, 16]. Conclusive recommendations for the
timing of smoking and alcohol cessation interventions
are therefore still lacking. On one hand cancer diagnosis
has been described as “a window of opportunity” to
change lifestyle [17–19]; patients with cancer diagnosis
are more likely to quit smoking than patients not diag-
nosed with cancer [20–22]. On the other hand, half of
patients with cancer who smoked before diagnosis con-
tinue to smoke during treatment [13, 20, 23]. This could
be attributed to the lack of effective interventions, but
also intrusive cancer treatment programs may counter-
act intentions to quit, due to challenging changes in
bodily function and body image [24, 25]. A commonly
described barrier that may prevent health professionals
from offering patients smoking cessation interventions is
that addressing smoking will be unwanted by the patient
or might imply judgement from the healthcare profes-
sionals [26, 27]. It is well-known that cancer survivors
are interested in lifestyle-interventions [28], but still little
is known about how cancer patients experience these
interventions [29, 30]. To our knowledge no studies have
investigated cancer patients’ experiences of following an
intensive smoking and alcohol cessation intervention in
relation to major surgery. Therefore, the aim of this
study was to explore how bladder cancer patients experi-
enced a perioperative smoking and alcohol cessation
intervention in relation to radical cystectomy.
Methods
The protocol for this study was written in compliance
with the COREQ guidelines [31]. The Danish Scientific
Ethical Committee System (16040244) evaluated the
study protocol and found formal appraisal of the study
to be unnecessary. The Danish Data Protection Agency
(2012–58-0004) approved the study. All patients
received both oral and written information and signed
informed consent before interviewing.
A qualitative descriptive design was adopted to obtain
in-depth knowledge about how newly diagnosed cancer
patients experienced the intensive smoking and alcohol
cessation interventions in relation to major bladder
surgery. Inspired by a phenomenological – hermeneut-
ical method [32] we conducted semi-structured in-depth
interviews. This study design provides the possibility to
understand the impact of the smoking and alcohol ces-
sation intervention in relation to radical cystectomy
from the patient perspective. The study formed part of
the STOP-OP study (Stop smoking and alcohol drinking
before operation for bladder cancer), a randomized con-
trolled trial evaluating the effect on postoperative com-
plications and quit rates of an intensive smoking and
alcohol cessation intervention in relation to radical
cystectomy [33]. The STOP-OP study has enrolled
patients since November 2014 and is expected to be
finalized at the end of 2017.
Sampling strategy
To elucidate the research question we used the principle
of purposeful sampling with maximum variation [34] to
achieve a varied sample with respect to: age, smoking,
alcohol drinking or both smoking and alcohol drinking
and success or failure in abstaining. Data was collected
until saturation [35].
Participants and setting
The interviews were conducted between November 2016
and May 2017. Fourteen patients were invited to partici-
pate in the qualitative study, three declined participation.
All participants were recruited from the STOP-OP
intervention group and asked for participation by the
study nurse after completion of the 6-weeks interven-
tion. Three patients had the interview conducted at
3 months follow-up, four at 6 months follow-up and
four at 12 months follow-up.
The interviews lasted 20–40 min and were all con-
ducted in two urological departments in connection with
a scheduled out-patient visit. Participants were offered
to have the interview in their own home, but everyone
preferred to be interviewed in the outpatient clinic.
The STOP-OP study
The STOP-OP study is an ongoing multi-center; ran-
domized, controlled trial with patients allocated to either
a smoking and/or alcohol cessation intervention initiated
shortly before radical cystectomy and lasting for a total
of 6 weeks; or to treatment as usual. Due to ongoing ef-
forts to accelerate diagnosis and treatment of patients at
suspicion of having cancer, in Denmark, the timeframe
for intervening before cancer surgery is maximum
14 days, often less. Inclusion criteria for the STOP-OP
study are: patients scheduled for radical cystectomy for
bladder cancer and who smoke daily and/or drink at
least 3 units of alcohol daily. One unit contains 12 g of
ethanol.
The smoking and alcohol cessation intervention
The intervention followed the principles of the Gold
Standard Programme (GSP) [36] (Table 1 shows the
content of the GSP). The principles of motivational
interviewing, balanced decision making and the trans-
theoretical model of change are the underlying tenets of
the programme [37]. The participants received
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counselling sessions before and after surgery during a
period of 6 weeks. Trained smoking and alcohol cessa-
tion counselors who, were also experienced urology
nurses, provided the intervention.
Data collection and analysis
Data was collected using face-to-face interviews which
were undertaken by two research nurses (TT and GK)
who were not directly involved in the STOP-OP inter-
vention or familiar with the patients. A semi-structured
interview guide with open-ended questions was prepared
beforehand to ensure coverage of the research question.
The interviewer asked broad questions to explore the in-
dividual person’s experience (See Additional file 1). The
introductory question was “How did you experience hav-
ing to deal with the cancer surgery and quitting smoking/
drinking at the same time?”
All interviews were recorded digitally and transcribed
verbatim. Interview transcripts were managed using the
software program QSR NVivo (Version 11). Coded data
were used to generate potential themes to facilitate ana-
lysis. The analysis followed the steps contained in the
thematic network analysis [38]. Themes were identified
and the network constructed, (Fig. 1 shows the network
for the main finding). In the analysis process we kept on
exploring the network by consulting the interview text
and finally we interpreted our findings.
Trustworthiness.
We assessed the rigor of our research regarding credibility,
dependability, transferability, and confirmability [35, 39] ac-
cording to the description of Guba [40]. To establish cred-
ibility we chose participants from the three different
interventions (smoking, alcohol drinking or both smoking
and alcohol drinking). During the interviews, experiences
described by the participants were restated by the inter-
viewers who then asked the participant to validate the state-
ments. In addition the interviewers had no former contact
with the participants or experience from bladder cancer
treatment. Thus, the participants were encouraged to be
frank from the outset of each session and they were assured
that there was no right or wrong answers to the questions
posed. Dependability was sought by step-wise replication as
the analysis was undertaken by LNL and SVL who
discussed their individual findings in each separate inter-
view. Next the findings were discussed in the whole
research group to identify the multiple realities experienced
by the participants. The description of participant charac-
teristics makes it possible for the reader to assess transfer-
ability to other bladder cancer patients. Confirmability was
sought obtained through the structure of the thematic net--
work identified and the quotations included in the presen-
tation of the findings.
Results
Eleven participants aged 43–77 were interviewed, 10
men and 1 woman, mean pack-year of smoking was 43,
indicating that the participants were all heavy smokers
(Table 2 lists characteristics of participants). At the time
of the interview five participants were still smoke-free or
had reduced alcohol drinking.
A global theme emerged to explain the participants’
experience of participating in a smoking and alcohol ces-
sation intervention in relation to radical cystectomy. We
present this as Smoking and alcohol cessation was expe-
rienced as an integral part of bladder cancer surgery.
Another global theme captured the participants’ experi-
ence of the time after surgery; Returning to everyday life
was a barrier for continued smoking cessation/alcohol
reduction.
Global theme: Smoking and alcohol cessation was
experienced as an integral part of bladder cancer surgery
The operation was the most urgent issue for participants
and the smoking-alcohol cessation programme merely a
minor part. The participants did not perceive the smoking
and alcohol intervention and undergoing surgery as two
separate entities. Rather, the intervention was perceived to
Table 1 Gold Standard Programme for smoking and alcohol
cessation intervention
Patient education programme
First meeting (before admission)
◦ Level of motivation, ambivalence, pros and cons
Second meeting (after 1 week)
◦ Dependence, withdrawal symptoms (experience and expectations)
Third meeting (after 2 weeks)
◦ Relapse (description and management)
Fourth meeting (after 3 weeks)
◦ Benefits of short and long term smoking and/or alcohol abstinence
Fifth meeting (after 5 weeks)
◦ Continued smoking abstinence and/or reduced alcohol intake
following intervention
At each meeting
Smokers: Personalized Nicotine Replacement Therapy (NRT) in accordance
with patient preferences and nicotine dependency
Risky drinkers: Thiamine and B-vitamins (300 mg × 7 weekly)
Alcohol withdrawal prophylaxis and treatment (chlordiazepoxide 10 mg
as required)
Disulfiram (200 mg × 2 weekly) supervised at weekly meetings (not
administrated if patients test positive on breath test)
All: Hemoglobin, liver enzymes and alcohol biomarkers (blood, urine), CO
and alcohol breath test, lung function test
The study medication is provided for free and transportation for the
weekly meetings will be reimbursed. Patients have telephone access to
the research nurse
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be an integral part of preparing for surgery. Moreover, in
addition to being a smoking-alcohol cessation interven-
tion, participants experienced that the intervention meet-
ings provided them with an extra source of support in the
bladder cancer pathway. The operation was the key issue
in the participants’ lives, and therefore the timing of inter-
vention meetings was of major importance for their mo-
tivation to participate. Participants did not find it difficult
to stop smoking or drinking alcohol in relation to radical
cystectomy, partly because smoking was prohibited in and
around the hospital, partly because they experienced side-
effects from surgery. Several participants reflected upon
their personal responsibility both towards own health,
family and also towards the smoking and alcohol cessation
counsellor and society.
Surgery was foreground, cessation background
Participants described that the cancer diagnosis and
undergoing radical cystectomy was a stressful
situation, but despite this participants were willing to
engage in the programme. Participants did not see
the smoking and alcohol intervention programme and
undergoing surgery as two separate entities. Rather
the intervention was seen as part of the preparation
for surgery.
Fig. 1 Thematic network for the main finding: the smoking and alcohol cessation intervention is experienced as an integral part of bladder
cancer surgery
Table 2 Characteristics of the 11 participants
Age at diagnosis, median (range) 58 (43–77)
Age at smoking debut, median (range) 15 (7–19)
Pack years, median (range) 43 (26–54)
Fagerström Nicotine Dependency score, median (range) 4.5 (3–6)
Smoking cessation intervention (n) 6
Alcohol cessation intervention (n) 3
Smoking and alcohol cessation intervention (n) 2
Smoke and alcohol free during the 6-weeks intervention (n)
Yes 8
No 3
Smoke-free /alcohol reduction at the interview (n)
Yes 5
No 6
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Well I haven’t seen it as though I had to do two things
(P10, alcohol intervention)
Well, for me the cancer was the major issue and the
other stuff sort of minor, right (P2, smoking
intervention)
It (the smoking intervention) didn’t become more of a
main issue because I had to have the surgery and it
wasn’t harder because I had to quit smoking and have
the surgery at the same time sort of (P3, smoking
intervention)
Timing of meetings
As the operation was the key issue in the participants’
lives, timing of meetings in the programme was of im-
portance. All meetings were planned in connection to
scheduled out-patient visits or as telephone calls. This
was of great importance to the participants because
many had a long way to travel to the hospital.
The participants stated that the intervention meetings
were supportive; they made them feel more comfortable
and allowed them to also ask questions related to their
treatment in general.
I said that the meetings had to be when I was in here
(the hospital), right? If they could do that, then fine
(P4, smoking intervention)
And I felt incredibly comfortable with it all. Especially
knowing that I was part of a process and part of a
programme (P11, alcohol intervention)
Surgery facilitates smoking and alcohol cessation
Participants did not find it difficult to stop smoking or
drinking alcohol in relation to radical cystectomy. The re-
strictive situation of being inside the hospital where smok-
ing was prohibited was a help to adhere to smoking
cessation. Side-effects of surgery such as nausea, oral
thrush or changes in taste due to medication also meant
that participants felt no desire to smoke or drink alcohol
during the hospital stay. Participants felt it was “strange”
that “I did not need it during hospitalization” when they
described the ease of abstinence at this time. Participants
in the alcohol intervention group were not surprised that
abstinence was easy, because they did not feel addicted to
alcohol beforehand. It seemed that surgery served as a
kind of refuge where the combination of the acceptance of
hospitals being smoke-free areas and the side-effects of
abdominal surgery facilitated smoking cessation.
When I go through that door downstairs, well then I
can’t smoke. Because – well I can’t because it’s not
allowed. So I don’t (P1, smoking and alcohol
intervention)
It was actually as though you have to now because
you’re going through all this and, strangely, I didn’t
miss it (P7, smoking intervention)
I got a yeast infection in my mouth and everything
tasted like kerosene or diesel, right. I couldn’t eat
anything and I lost about 6-7 kilos while I was there.
And I didn’t even think about smoking at all (P8,
smoking intervention)
My operation – My responsibility
Even though most participants felt that cessation was a
personal responsibility and a matter of willpower, they
also described the motivation to participate in the inter-
vention as an obligation either towards their own health,
family, healthcare professionals, or society. Most partici-
pants were aware of the importance of their behavior
and the patient-counsellor interaction. The wish to be “a
good patient persona” doing what both family and
healthcare professionals expected encouraged the partic-
ipants to cessation.
Now, at last, someone offered to help me and it’s a good
offer of help with nicotine replacement therapy and all
that… Yeah, you don’t want to lose face and have to
say… And because my family, we’ve talked about the
cancer in my family and ah also that you have to stop
smoking and all that, you know (P2, smoking
intervention).
Repeatedly participants expressed that people are per-
sonally responsible and that cessation can only be
achieved through willpower. One participant also
reflected upon the consequences of the hospital not re-
quiring patients to stop smoking and drinking alcohol in
relation to surgery.
I ought to join a quit programme of my own accord at
home, right…. For me it’s mainly about willpower, I
mean I lack willpower. I don’t have the last bit (P7,
smoking intervention)
You should more or less demand that people stop smoking
before major surgery; I mean surgery is expensive for
society. And I think it would be reasonable, as part of the
treatment, to ask people to be abstinent (P11, alcohol
intervention)
In-hospital support
The empathic approach underlying the intervention was
of importance and was seen both as a support to cessa-
tion and as a support in the postoperative period. Sev-
eral participants felt more motivated when healthcare
professionals encouraged them to cessation. Some
Lauridsen et al. BMC Cancer  (2017) 17:793 Page 5 of 9
underpinned that a paternalistic approach would have
made them continue smoking out of spite.
For me it’s positive that she’s such a nice person. She
doesn’t say you can’t do this or you’re not allowed that
because that would make me become stubborn and
say I’m going to smoke regardless (laughing) (P9,
smoking intervention)
I got raised fingers from doctors and nurses that it
would be a good idea if I didn’t smoke in connection
with my surgery (P2, smoking intervention)
Global theme: Returning to everyday life was a barrier for
continued smoking cessation/alcohol reduction
Returning to everyday life and feeling better played an
important role in the risk of relapse. Context specific
factors like negative affect, social-food situations and
habit-driven smoking and drinking were given as reasons
for relapse.
Lifestyle
Restoration to health and resumption of one’s habitual
lifestyle were described as critical for either maintaining
lifestyle changes or for relapse. Participants expressed
that feeling better or stressful situations were reasons for
relapses. Despite the fact that only one participant in the
alcohol intervention group thought he was a heavy
drinker, all participants described that they maintained
changes in lifestyle after completion of the intervention.
These changes were motivated by referring to the
benefits of weight loss, improved sleep and being more
conscious of listening to their body. No participants
mentioned heavy alcohol drinking as the motivation for
lifestyle changes.
Maybe I just felt a little better, I don’t know, and then
when I was told that the cancer had possibly spread I
thought sod it all – I’m going to have a fag. And then
– well before you know it you’re smoking as much as
you used to (P3, smoking intervention)
But then I started to feel really, in fact really normal
again. So I started to smoke because I was able to
start working more, right (P8, smoking intervention)
I found out that I’ve lost almost 10 kilos …. So there’s
no reason to start drinking and putting on weight
again (P7, alcohol intervention)
For some participants smoking and drinking alcohol
were major parts of socializing with family and friends
and this was a barrier to maintaining the new lifestyle.
Some mentioned that the chance of maintaining cessation
would have been increased by attending group sessions as
they would then become part of a new social group.
Yes… It happened— I think it was at a party or
something I was talking to a family member and well
– okay I’ll just smoke one cigarette with you, right.
And then I started again (P7, smoking intervention)
It could be a Sunday lunch with the family; it could be
with close friends, especially if you’re on holiday with
friends, right. It’s nice with some rose wine and a
barbecue… I haven’t cut down on situations but I’ve
cut down on how much I drink in those situations
(P10, alcohol intervention)
Breaking habits
The replacement of a habitual response with an alterna-
tive response in situations where the participants used to
smoke or drink alcohol could overrule habits and for
some this was a deliberate coping strategy.
As soon as I’ve finished eating and I can feel the
craving coming, I get up and take the plates out and
start washing them or whatever I can think of (P4,
smoking intervention)
Yes, I thought a lot about that, it was hard to find a
replacement. When I’m out I always bring sparkling
water. In that way I fill myself with something else
(P10, alcohol intervention)
Some participants experienced family as supportive,
but the converse was also seen. Patients who experi-
enced pressure from relatives to stop smoking empha-
sized that the decision was theirs alone and they
experienced the family’s concern as “nagging” rather
than caring.
It’s both that you can motivate each other because my
wife, I mean she can motivate me but actually she can
also demotivate me. She gets upset and also a bit mad
at me when I keep on smoking. I can easily
understand her reaction (P7, smoking intervention)
Particularly when my wife sees the ashtray she tells me
off (…). Yes if someone starts saying that I have to,
then I won’t, not for anything (P9, smoking
intervention)
Replacing a habitual response with an alternative re-
sponse was successful for some to maintain cessation
and to reduce consumption. Others were very confident
that they would not relapse.
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I don’t think so. I think I would have by now… already
have had withdrawal symptoms and now I’m convinced
that nothing will happen. So I’m quite sure that I’m over
it. And I can thank the smoking cessation counselors for
that (P2, smoking intervention)
This man was interviewed at 12 – months follow-up and
was still smoke-free.
Discussion
The participants interviewed in this study experienced the
smoking and alcohol intervention as a relevant offer in re-
lation to major bladder cancer surgery. The intervention
and surgery were the main factors supporting cessation;
both the timing and the setting were pointed out as im-
portant and the empathic approach inherent in the inter-
vention and the contact to the counselors was also
experienced as supportive. Despite the fact that cessation
during hospitalization felt easy for all participants, return-
ing to everyday life challenged continued smoking abstin-
ence and reduced alcohol intake in most participants.
There are some limitations to this study. Participants
were all recruited from the intervention group in the
STOP-OP study and are likely to represent a somewhat
motivated group, having voluntarily taken part in the
STOP-OP trial. Furthermore only one woman was inter-
viewed. As bladder cancer is four times more likely to
occur in men [41], we found this distribution of gender
acceptable.
A strength of this study is that participants were inter-
viewed at different times after surgery and thus provided
knowledge about the impact of the 6-week intervention
both short-term and long-term.
The meetings in this study were all held at the uro-
logical department, often in connection with bladder
cancer follow-up visits and the counselors were all
experienced urology nurses. This might have contributed
to the experience of the smoking and alcohol cessation
intervention as an integral part of surgery. This is in line
with the study from Sharp et al. who also found that in-
tegrating the smoking cessation process with other care
needs, and viewing the intervention as an intrinsic part
of the patient’s anti-cancer treatment, facilitated smoking
cessation [42]. The participants’ experience of the
smoke-free hospital as supportive of cessation confirms
the effect of the WHO recommendation that all people
should be protected from exposure to tobacco smoke
and that all indoor workplaces and indoor public places
should be smoke free. [43].
It is interesting that several studies have identified that
the attitudes of healthcare professionals are a major
barrier to offering smoking cessation interventions
[26, 27, 44, 45], while studies exploring both cancer
and non-cancer patients’ attitudes show the opposite
[29, 30, 46, 47]. This contradiction in attitudes can be
overcome by communicating the patients’ perspectives on
clinical health promotion to healthcare professionals.
This study adds to the evidence that every contact
with a cancer patient poses an opportunity for health-
care professionals to engage in health promotion.
Laying the blame for continued smoking on them-
selves and the belittlement of nicotine dependency
among the study participants is consistent with the find-
ings of Morphett et al.[48]. They also found that despite
meticulous explanations about the neurobiological basis
of addiction the participants stated they remained per-
sonally responsible for continued smoking. This might
explain why returning to everyday life is a challenge. As
patients recover from surgery, they will increasingly
encounter situations where they used to smoke or drink
alcohol and subsequently, face the risk of succumbing to
the power of usual habits.
Our findings point to the feasibility of enhancing the
effect of physicians’ advice [49] about smoking and
alcohol cessation by involving urology nurses educated
in smoking and alcohol counselling in delivering cessa-
tion interventions in relation to surgery.
Conclusion
The smoking and alcohol cessation intervention was well
received by the participants. This is the first study explor-
ing heavy smokers and risky drinkers’ experiences of a 6
week smoking and alcohol cessation intervention in rela-
tion to bladder cancer surgery. Our results add new
insight to existing evidence that patients do want support
to stop smoking and risky drinking during hospitalization,
but also to the need for continued support when returning
to everyday life. Our findings point both to the need to
educate healthcare professionals in providing smoking
and alcohol cessation interventions and to further explore
if a follow-up intervention after the initial hospital-based 6
week intervention would support long-term cessation. If
the results of the STOP-OP study support these findings
we will look into the feasibility of addressing smoking ces-
sation and alcohol reduction at each follow-up meeting in
the urological outpatient clinic.
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